Physician

David Nasrazadani, MD

According to 2025 Medicare claims, David Nasrazadani, MD (NPI: 1922529536) practices ophthalmology in the Springfield, MO market, with the plurality of this provider's patient population coming from Greene, MO. This provider's primary affiliated billing organization is MATTAX NEU PRATER EYE CENTER, INC. (NPI: 1790745313; TIN: 431842769) and primary practice location at 65804-4278.

Nasrazadani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 487 traditional Medicare patients, billed 4,385 HCPCS/CPT codes, and received $762,560 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 1,415 prescription claims across 356 beneficiaries totaling $116,233 in drug costs, led by Xiidra (Lifitegrast). Open Payments data shows 17 records totaling $587. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,448 to $116,233. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.